other material
confidence high
sentiment neutral
materiality 0.60
Enveric Biosciences raises $3.1M via warrant exercise inducement at $7.05 per share
Enveric Biosciences, Inc.
- Gross proceeds of ~$3.1M from cash exercise of 426,390 existing warrants at reduced price of $7.05/sh.
- Issued new Series E warrants (5-yr term) and Series F warrants (18-mo term) for up to 426,390 shares each at $7.05.
- H.C. Wainwright served as placement agent; fees of 7.0% of gross proceeds plus placement agent warrants.
- Net proceeds allocated to product development, working capital, and general corporate purposes.
- Company to file resale registration statement for new warrant shares within 10 days.